Medicare AdvantagePrior AuthMedium impact
26-1012m Updates to Medicare Clinical Policies – July 2026
Health Net·CA · Transplant Surgery, General Surgery, Wound Care·Prior Authorization
Effective date
Jul 1, 2026
We identified it
Aug 18, 2026
Summary
Centene Medicare released four clinical policy updates effective July 2026: SNF Leveling formatting changes with removal of high-cost drug administration criteria, Hematopoietic Progenitor Cell Therapy annual review updates, Transplant Service Documentation requirements extended from 6 months to 12 months authorization validity, and Skin/Soft Tissue Substitutes corrections including addition of HCPCS code Q4432. Most changes are administrative; the transplant authorization extension requires immediate workflow updates.
Action Required
By July 1, 2026: (1) Billing team must update prior authorization tracking system to reflect that transplant evaluations (policy MC.CP.MP.247) are now valid for 12 months instead of 6 months—update authorization expiration logic to prevent unnecessary re-authorizations. (2) Update encounter templates and provider communication to reflect 12-month transplant eval validity. (3) Billing team must add HCPCS code Q4432 to skin/soft tissue substitute billing codes in system (policy MC.CP.MP.185). (4) Remove high-cost drug administration from SNF Leveling prior authorization requirements (policy CC.PP.206)—update billing rules to eliminate PA denials for these claims. (5) Notify transplant surgery providers of extended authorization window. Failure to implement may result in incorrect claim denials for transplant-related services and improper SKF claims processing.